TGA regulation of PRP procedures
In July 2018, the Australian Therapeutic Goods Administration (TGA) tightened regulation governing all blood products & biological materials and further legislation was introduced.
All Alocuro devices are listed on the TGA’s ARTG register as medical devices
All facets of Alocuro protocol meet the current TGA regulations and the PRP produced is ‘regulated as blood components but exempt from most regulation requirements’ when PRP procedures have medical practitioner oversight.
The PRP that Alocuro PRP system produces is therefore allowed to be performed outside of a hospital and advertised to the public because it meets all of the following criterion:
To note, at this time, it is medical practitioners only that can provide the ‘professional supervision’ requirement. TGA Biologicals department have advised that nurse practitioners do not fulfill the TGA legislated requirements for professional supervision of PRP procedures.
There is no restriction on advertising your PRP service when:
Where one or more above criteria are not met, the exemptions from TGA regulatory requirements do not apply, and the product will be regulated as a ‘Biological’. This means the procedure cannot be performed unless the strict “Biological” regulations are met and the procedures cannot be advertised to the public.